Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00265148
Recruitment Status : Completed
First Posted : December 14, 2005
Last Update Posted : November 16, 2016
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2008
  Actual Study Completion Date : July 2008
  Certification/Extension First Submitted : October 13, 2010
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 July 26, 2017
August 24, 2017
2 December 4, 2017
January 3, 2018
3 January 10, 2018
February 6, 2018